News & Events

  • 07 Apr 2015
  • Hetero launches Sofovir (Sofosbuvir) in India
  • Hyderabad-based pharmaceutical company Hetero Drugs have received the approval from the Drugs Controller General (India) to sell generic versions of sofosbuvir tablets (400 mg) in India.

    Sofosbuvir is a blockbuster drug to treat chronic hepatitis C infection and is sold globally by US pharmaceutical major Gilead Sciences under its brand Sovaldi. Gilead recently entered into non-exclusive licensing agreements with the two companies and six other Indian generic pharmaceutical manufacturers to make generic versions of the drug.

    Hetero Drugs is launching it under the brand Sofovir, Hetero Drugs said and “Hetero  will be selling to all 91 countries over the next 6-9 months, Hetero have to register in each market after India and will  start with the ASEAN countries and then go to other markets.”